Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glioma-associated oncogene homologue 1 (GLI1) is a zinc finger transcription factor and a key effector of the Hedgehog (Hh) signaling pathway. It functions primarily as a transcriptional activator, regulating genes involved in cell cycle progression, migration, invasion, and survival. GLI1 overexpression is observed in various cancers, including gliomas and breast carcinomas, making it an attractive target for anti-cancer therapy. Targeting the Hh–Gli axis could impact tumor growth/survival across multiple cancer types.
Modulation or inhibition of the Hh-Gli axis
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glioma-associated oncogene homologue protein 1 (GLI1).